Adapting the European Concerted Action on Congenital Anomalies and Twins (<scp>EUROCAT</scp>) Guide 1.5 for Use in Post‐Authorisation Safety Studies Using US Data
We adapted the EUROCAT Guide 1.5 into an ICD-10-CM code list for use in pregnancy studies using US data sources. This list includes new ICD-10-CM codes available in 2024. As new ICD-10-CM codes become available, or as the EUROCAT Guide is updated, further updates to this list will be needed.
Authors
- Sarah R. Hoffman (ORCID: https://orcid.org/0000-0001-5629-160X)
- Stephan Lanes (ORCID: https://orcid.org/0000-0001-9536-6643)
- Todd R. Sponholtz (ORCID: https://orcid.org/0000-0003-4647-5354)
- Krista Schroeder (ORCID: https://orcid.org/0000-0002-0589-2613)
- Vincent J. Willey (ORCID: https://orcid.org/0000-0002-6473-6469)
- Aziza Jamal‐Allial (ORCID: https://orcid.org/0000-0001-7039-8833)
- Erin D. Foster (ORCID: https://orcid.org/0000-0001-6908-9849)
- J. Bradley Layton (ORCID: https://orcid.org/0000-0003-0994-5820)
- Corinne Brooks (ORCID: https://orcid.org/0000-0002-8012-1149)
- M.C.Navarrete Guzman
- Oluwadamilola Onasanya (ORCID: https://orcid.org/0009-0007-6473-3624)
- Nadia Messeh
- Dawn Ponist
- Maryline L. E. Noan‐Lainé
- Geetika Kalloo
- Maria I. Van Rompay
Institutions
- Eli Lilly (United States) (US)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/pds.70109
- Primary Topic
- Prenatal Screening and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00